Plichta Jennifer K, Thomas Samantha M, Chanenchuk Tori C, Chan Kelley, Hyslop Terry, Hwang E Shelley, Greenup Rachel A
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Department of Population Health Sciences, Duke University Medical Center, Durham, North Carolina, USA.
Cancer. 2025 Jan 1;131(1):e35525. doi: 10.1002/cncr.35525. Epub 2024 Aug 18.
This study compared incident breast cancer cases in the National Cancer Database (NCDB) and Surveillance, Epidemiology, End Results Program (SEER) to a national population cancer registry.
Patients with malignant or in situ breast cancer (BC) 2010-2019 in the NCDB and SEER were compared to the US Cancer Statistics (USCS). Case coverage was estimated as the number of patients in the NCDB/SEER as a proportion of USCS cases.
The USCS reported 3,047,509 patients; 77.5% patients were included in the NCDB and 46.0% in SEER. Case ascertainment varied significantly by patient sex (both registries, p < .001). For males, 84.1% were captured in the NCDB, whereas only 77.5% of females were included. Case coverage in SEER was better for females than males (46.1% vs. 43.5%). Registries varied significantly by race/ethnicity (both p < .001). Case coverage in the NCDB was highest for non-Hispanic White (78.2%), non-Hispanic Black (77.7%), and non-Hispanic Asian or Pacific Islander (72.5%) BC patients, and lowest for Hispanic (56.4%) and non-Hispanic American Indian/Alaska Native (41.1%) patients. In SEER, case coverage was highest for non-Hispanic Asian or Pacific Islander (78.1%) and Hispanic (69.6%) patients and it was significantly lower for all other subgroups (non-Hispanic Black, 44.8%; non-Hispanic White, 42.4%; and non-Hispanic American Indian/Alaska Native, 36.6%).
National US tumor registries provide data for a large sampling of breast cancer patients, yet significant differences in case coverage were observed based on age, sex, and race/ethnicity. These findings suggest that analyses using these data sets and interpretation of findings should account for these meaningful variances.
本研究将国家癌症数据库(NCDB)和监测、流行病学与最终结果计划(SEER)中的乳腺癌发病病例与一个国家人口癌症登记处进行了比较。
将2010 - 2019年NCDB和SEER中患有恶性或原位乳腺癌(BC)的患者与美国癌症统计数据(USCS)进行比较。病例覆盖范围以NCDB/SEER中的患者数量占USCS病例数的比例来估计。
USCS报告了3,047,509例患者;77.5%的患者被纳入NCDB,46.0%的患者被纳入SEER。病例确诊情况因患者性别差异显著(两个登记处,p <.001)。对于男性,84.1%被NCDB捕获,而女性只有77.5%被纳入。SEER中女性的病例覆盖情况优于男性(46.1%对43.5%)。登记处因种族/民族差异显著(均p <.001)。NCDB中,非西班牙裔白人(78.2%)、非西班牙裔黑人(77.7%)和非西班牙裔亚洲或太平洋岛民(72.5%)乳腺癌患者的病例覆盖最高,西班牙裔(56.4%)和非西班牙裔美国印第安人/阿拉斯加原住民(41.1%)患者的病例覆盖最低。在SEER中,非西班牙裔亚洲或太平洋岛民(78.1%)和西班牙裔(69.6%)患者的病例覆盖最高,其他所有亚组(非西班牙裔黑人,44.8%;非西班牙裔白人,42.4%;非西班牙裔美国印第安人/阿拉斯加原住民,36.6%)的病例覆盖则显著较低。
美国国家肿瘤登记处为大量乳腺癌患者提供了数据,但基于年龄、性别和种族/民族观察到病例覆盖存在显著差异。这些发现表明,使用这些数据集进行分析以及对研究结果的解释应考虑这些有意义的差异。